In the neurological environment, Siemens has introduced a sophisticated computer-aided brain function database for SPECT and PET, SPECT/CT and other multimodalities with syngo Scenium. The analysis tool allows physicians to assess abnormalities by automatically correlating patient studies with average brains.
Siemens also introduced imaging biomarkers to help physicians detect both ß-amyloid plaques and neuronal tangles to predict the onset of dementia and neurological disorders. As Siemens strives to provide physicians with the tools to deliver earlier treatment, it is developing better drugs to effectively manage the progression of disease.
January 27, 2026 
